5 ms·
The claim is largely true for drug development, but not for routine procedures. Those are expensive for unrelated, and largely pathological, reasons.
by mjewkes 4y ago
The claim is largely true for drug development, but not for routine procedures. Those are expensive for unrelated, and largely pathological, reasons.
- mrtksn 4y agoOkay, can you provide some literature on that claim? Do you, by any chance refer to the European governments buying directly from the pharma companies, thus getting solid discount? Or is it the case that European companies simply copy the drugs and move on? If that's the case, is the US healthcare expensive because pharma companies need to make money from the US sales only?
- mjewkes 4y agohttps://www.rand.org/pubs/research_briefs/RB9412.html https://www.rand.org/pubs/research_briefs/RB9412.html and The Great American Drug Deal, by Peter Kolchinsky. Specific claims: - The US pays more for new drugs than the rest of the world - The US contribution is disproportionate, and is major driver of the drug development industry. -If the US paid less for new drugs, the entire industry would slow, and we would have fewer more effective treatments.